JAC Advance Access originally published online on September 8, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy 2004 54(4):821-823; doi:10.1093/jac/dkh427
JAC vol.54 no.4 © The British Society for Antimicrobial Chemotherapy 2004; all rights reserved
Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii
Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Goldenfelsstrasse 1921, 50935 Cologne, Germany
* Corresponding author. Tel: +49-221-4783071; Fax: +49-221-4783067; Email: paul.higgins{at}uni-koeln.de
Objectives: To investigate the mechanism of ciprofloxacin resistance in isolates of Acinetobacter baumannii during two hospital outbreaks and to determine the expression level of the gene encoding the AdeB efflux pump.
Methods: Isolates were previously typed by PFGE and their MICs determined by broth microdilution. The gyrA and parC genes were sequenced and the adeB gene examined by real-time reverse transcription PCR (RT-PCR).
Results: Two clonal lineages were responsible for the two hospital outbreaks. In both outbreaks, ciprofloxacin susceptibility was reduced during the course of the outbreak when compared with the index isolates. Mutations in gyrA and parC were found to have occurred during the outbreak. The MICs of non-fluoroquinolone antibiotics were raised in one clonal lineage and this was associated with a >10-fold increase in mRNA transcripts for adeB.
Conclusions: We have witnessed the appearance of gyrA and parC mutations during outbreaks of A. baumannii. In parallel with these mutations, we observed up-regulation of the adeB gene associated with a decrease in susceptibility to non-fluoroquinolone antibiotics. These data illustrate the propensity for A. baumannii to develop multi-drug resistance rapidly.
Keywords: ciprofloxacin , efflux , RT-PCR , multidrug resistance
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Figueiredo, L. Poirel, J. Croize, C. Recule, and P. Nordmann In Vivo Selection of Reduced Susceptibility to Carbapenems in Acinetobacter baumannii Related to ISAba1-Mediated Overexpression of the Natural blaOXA-66 Oxacillinase Gene Antimicrob. Agents Chemother., June 1, 2009; 53(6): 2657 - 2659. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Hujer, A. M. Hujer, A. Endimiani, J. M. Thomson, M. D. Adams, K. Goglin, P. N. Rather, T.-T. D. Pennella, C. Massire, M. W. Eshoo, et al. Rapid Determination of Quinolone Resistance in Acinetobacter spp. J. Clin. Microbiol., May 1, 2009; 47(5): 1436 - 1442. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-L. Lu, M. Doumith, D. M. Livermore, T.-P. Chen, and N. Woodford Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase J. Antimicrob. Chemother., April 1, 2009; 63(4): 641 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Beceiro, A. Perez, F. Fernandez-Cuenca, L. Martinez-Martinez, A. Pascual, J. Vila, J. Rodriguez-Bano, J. M. Cisneros, J. Pachon, G. Bou, et al. Genetic Variability among ampC Genes from Acinetobacter Genomic Species 3 Antimicrob. Agents Chemother., March 1, 2009; 53(3): 1177 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. H. Tam, K. R. Ledesma, G. Vo, S. Kabbara, T.-P. Lim, and M. Nikolaou Pharmacodynamic Modeling of Aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: Identifying Dosing Regimens To Suppress Resistance Development Antimicrob. Agents Chemother., November 1, 2008; 52(11): 3987 - 3993. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Curcio Comment: Tigecycline for the Treatment of Acinetobacter Infections: A Case Series Ann. Pharmacother., November 1, 2008; 42(11): 1717 - 1718. [Full Text] [PDF] |
||||
![]() |
S. Bratu, D. Landman, D. A. Martin, C. Georgescu, and J. Quale Correlation of Antimicrobial Resistance with {beta}-Lactamases, the OmpA-Like Porin, and Efflux Pumps in Clinical Isolates of Acinetobacter baumannii Endemic to New York City Antimicrob. Agents Chemother., September 1, 2008; 52(9): 2999 - 3005. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Valentine, D. Contreras, S. Tan, L. J. Real, S. Chu, and H. H. Xu Phenotypic and Molecular Characterization of Acinetobacter baumannii Clinical Isolates from Nosocomial Outbreaks in Los Angeles County, California J. Clin. Microbiol., August 1, 2008; 46(8): 2499 - 2507. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Peleg, H. Seifert, and D. L. Paterson Acinetobacter baumannii: Emergence of a Successful Pathogen Clin. Microbiol. Rev., July 1, 2008; 21(3): 538 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Hu, S.-M. Yao, C.-P. Fung, Y.-P. Hsieh, C.-P. Liu, and J.-F. Lin An OXA-66/OXA-51-Like Carbapenemase and Possibly an Efflux Pump Are Associated with Resistance to Imipenem in Acinetobacter baumannii Antimicrob. Agents Chemother., November 1, 2007; 51(11): 3844 - 3852. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nemec, M. Maixnerova, T. J. K. van der Reijden, P. J. van den Broek, and L. Dijkshoorn Relationship between the AdeABC efflux system gene content, netilmicin susceptibility and multidrug resistance in a genotypically diverse collection of Acinetobacter baumannii strains J. Antimicrob. Chemother., September 1, 2007; 60(3): 483 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vila, S. Marti, and J. Sanchez-Cespedes Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii J. Antimicrob. Chemother., June 1, 2007; 59(6): 1210 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Peleg, J. Adams, and D. L. Paterson Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii Antimicrob. Agents Chemother., June 1, 2007; 51(6): 2065 - 2069. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ruzin, D. Keeney, and P. A. Bradford AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex J. Antimicrob. Chemother., May 1, 2007; 59(5): 1001 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pannek, P. G. Higgins, P. Steinke, D. Jonas, M. Akova, J. A. Bohnert, H. Seifert, and W. V. Kern Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-{beta}-naphthylamide J. Antimicrob. Chemother., May 1, 2006; 57(5): 970 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Z. Su, J. Chen, T. Mizushima, T. Kuroda, and T. Tsuchiya AbeM, an H+-Coupled Acinetobacter baumannii Multidrug Efflux Pump Belonging to the MATE Family of Transporters Antimicrob. Agents Chemother., October 1, 2005; 49(10): 4362 - 4364. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Huys, M. Cnockaert, A. Nemec, and J. Swings Sequence-Based Typing of adeB as a Potential Tool To Identify Intraspecific Groups among Clinical Strains of Multidrug-Resistant Acinetobacter baumannii J. Clin. Microbiol., October 1, 2005; 43(10): 5327 - 5331. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Bartual, H. Seifert, C. Hippler, M. A. D. Luzon, H. Wisplinghoff, and F. Rodriguez-Valera Development of a Multilocus Sequence Typing Scheme for Characterization of Clinical Isolates of Acinetobacter baumannii J. Clin. Microbiol., September 1, 2005; 43(9): 4382 - 4390. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Drago, E. De Vecchi, L. Nicola, L. Tocalli, and M. R. Gismondo In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with {beta}-lactams and amikacin J. Antimicrob. Chemother., August 1, 2005; 56(2): 353 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Poole Efflux-mediated antimicrobial resistance J. Antimicrob. Chemother., July 1, 2005; 56(1): 20 - 51. [Abstract] [Full Text] [PDF] |
||||




